Patents by Inventor Juan Carlos Tercero Lopez

Juan Carlos Tercero Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prognostic Molecular Markers for ET-743 Treatment
    Publication number: 20100267732
    Abstract: The present invention relates to the use of ecteinascidin 743 in human patients having certain molecular markers profile which has been associated with the outcome of ET-743 chemotherapy. In particular, the invention relates to the use of ecteinascidin 743 in patients having high expression levels of XPG mRNA or protein and/or having a “wild type” genotype for Asp1104His SNP of XPG gene.
    Type: Application
    Filed: October 20, 2008
    Publication date: October 21, 2010
    Applicant: PHARMA MAR, S.A.
    Inventors: Rafael Rosell Costa, Miguel Tarón Roca, Nerea Martínez Magunacelaya, Ana Díez Rodríguez, José Mª Jimeno Donaque, Juan Carlos Tercero López
  • Prognostic Molecular Markers
    Publication number: 20080293725
    Abstract: The present invention relates to the use of ecteinascidin 743 in patients having certain levels of molecular markers who can predict the outcome of chemotherapy, in particular in patients having low levels of BRCA1 expression.
    Type: Application
    Filed: July 11, 2005
    Publication date: November 27, 2008
    Inventors: Rafael Rosell Costa, Miguel Taron Roca, Jose Maria Jimeno Donaque, Juan Carlos Tercero Lopez